News Sanofi scores in MS with CD40 antibody frexalimab Sanofi has posted encouraging results with one of its mid-stage candidates for multiple sclerosis, anti-CD40L
News PBM reform dropped in Congress' funding package Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
